$CDIX ~Merger with CDB Oil Co. Acela~ Updated DD
1) CDIX
$CDIX ~Merger with CDB Oil Co. Acela~ Updated DD
1) CDIX is going to merge with Acela Biomedical, LLC
FT. LAUDERDALE, Fla., Aug. 23, 2019 (GLOBE NEWSWIRE) -- Cardiff Lexington Corporation (OTC:CDIXBB) and Acela BioMedical, LLC in Maysville, Ky announced today that they have signed a Letter of Intent whereby Acela BioMedical would become a subsidiary of Cardiff Lexington.
The parties have been in confidential discussions and negotiations for several months having reached agreement in principal and are working diligently to finalize their transaction as visualized in their recently executed Letter of Intent.
CDIX website: https://www.cardifflexington.com
https://www.globenewswire.com/news-release/20...Merge.html
2) Acela Biomedical is a very legit company. One of the biggest CBD oil producer in USA
Watch
news video about Acela Facility https://www.wlwt.com/article/cbd-products-wha...w/28748027
Acela's
CBD oil products !
https://acelacbd.com/shop/
Acela
Facebook page https://www.facebook.com/acelacbd/
Acela CBD
instagram page !
https://www.instagram.com/acelacbd/
3) Congressman Thomas Massie visited the Acela CBD facility in Maysville, Kentucky
12 August at 08:38 ·
I had the opportunity to tour the Acela CBD facility in Maysville, Kentucky last week. It’s always exciting to see how the new industrial hemp industry has boosted the economy in Kentucky—especially when I’m able to wear a lab coat which reminds me of my days at the Massachusetts Institute of Technology. Acela CBD is a particularly innovative startup. This company is entirely local, contracting with Kentucky farms to supply industrial hemp, honey, lemongrass, lavender, and other ingredients to use in their own products.
Thanks to Acela CBD CEO Andrew Culbertson and Basil Mattingly for your hospitality and conversation.
https://en-gb.facebook.com/pg/acelacbd/posts/
4) Acela represents 10% of Kentucky's hemp growers . The company will produce up to 9,000 liters of CBD oil per month by 2020.
The Company recently put out a letter of intent to merge with Acela Biomedical, LLC and asked about this new development. Cunningham explained that Acela Biomedical is a clinical stage Biotech verified hemp grower, distributor, processor, extractor, and retailer that specializes in CBD oil production. "We think our partnership with Acela Biomedical affords Cardiff Lexington an incredible opportunity.", said Cunningham. He further explained that the Acela Biomedical offers soil-to-bottle CBD that has been rigorously tested for its quality, while also providing leading extraction methods. "Acela represents 10% of Kentucky's hemp growers.", added Cunningham.
Cunningham continued to elaborate on Acela Biomedical's cutting edge CBD processes, and shared that the Company expects that their new partner will produce up to 9,000 liters of CBD oil per month by 2020. "That's really important when you understand that one liter of high-quality CBD oil sells for $1,000-$3,000 on the market."
To hear Alex Cunningham's entire interview, follow the link to the podcast here: https://audioboom.com/posts/7357428-cardiff-l...to-the-hem
https://finance.yahoo.com/news/cardiff-lexing...c=fin-srch
5) CDIX eliminated convertible notes and working with non dilutive private equity firms.
http://www.globenewswire.com/news-release/201...Debts.html
6) CDIX~ update out~ float 382 million NO CHANGE since last PR out.
https://www.otcmarkets.com/stock/CDIX/security
7) CDIX's most recent news
https://www.otcmarkets.com/stock/CDIX/news
Scroll down for more posts ▼
Top 10 Most Recent News Articles
ROKAE's Big 10K: A Milestone Worth Noting Alright, if you've been around the block as long as I have, you know the robotics game isn't just about making cool gadgets—it's about hitting those serious deployment numbers. ROKAE Robotics just rolled its 10,000th humanoid force-controlled arm off the line in Shandong, and this ain't just another notch on their belt. This...
Continue Reading
Shenzhen Steps into the Arbitration Spotlight In a move that's bound to tweak some eyebrows in the legal realm, Shenzhen just hosted the 2026 Foreign Direct Investment International Arbitration Moot (FDI Moot) Global Finals. This marks the first time the finals have landed on Chinese soil, and folks, that's a big deal. It’s a hefty nod to China's expanding credibility...
Continue Reading
Riding the Waves of Reform in China The winds of change are blowing through China's capital markets, and Guosen Securities is putting a stake in the ground with bold priorities for the 15th Five-Year Plan. As far as I'm concerned, the headlines here are thick with implications for anyone eyeing a piece of China's economic pie from 2026–2030. The Pillars of Stability and...
Continue Reading
CStone's Game-Changer: CS2009 in the Spotlight CStone Pharmaceuticals just pulled a rabbit out of a hat at the ESMO 2026 Congress, showcasing the clinical might of their CS2009. This ain't just another hype train, folks. We're talking about a trispecific antibody targeting PD-1, VEGF, and CTLA-4. With data rolled out from over 300 patients, this compound promises a...
Continue Reading
Elbit Systems Secures Major Asia-Pacific Deal You know, it's not every day that a defense contractor like Elbit Systems (NASDAQ:ESLT) bags a $200 million deal in the Asia-Pacific region. A big move in a high-stakes game where technology, strategy, and geography collide. This isn't some random supply deal; this involves the cutting edge of defense tech—ISTAR and training...
Continue Reading
Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...
Continue Reading
Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...
Continue Reading
Zinzino's Strategic Play in Europe's Wellness Market There's a new player on the European wellness block, and it's Zinzino's latest concoction of fermented botanical supplements. This isn't just your run-of-the-mill vitamin shop stock; we're talking about a lineup crafted for distinct parts of the day, reflecting an evolving consumer trend. People are looking for tailored...
Continue Reading
Fluence Energy Faces a Securities Fraud Challenge It's like watching a slow-motion train wreck. Fluence Energy, Inc. (NASDAQ: FLNC) now finds itself in the crosshairs of a securities fraud class action lawsuit. Apparently, someone was playing fast and loose with the truth concerning their financial guidance. The period in question stretches from November 24, 2025, to...
Continue Reading
Tax Filing Today: The Old vs. The New Listen up, tax-filing warriors. Tackling that IRS Form 941 deadline isn’t just another play in the small business game—it’s crunch time. November 2, 2026, isn’t waiting around for excuses. Luckily, Halfpricesoft.com just chucked you a lifeline with their updated ezPaycheck platform. Swap that mountain of mangled paper forms...
Continue Reading
Top 5 Most Recently Viewed Articles
Shannon McGhee Takes the Helm at SEED SPOT SEED SPOT, a national social impact incubator focused on uplifting purpose-driven entrepreneurs, is excited to announce the appointment of Shannon McGhee as its new Chief Executive Officer. This leadership change marks a significant milestone for the organization as it steps towards its next chapter of growth. McGhee's Rich...
Continue Reading
Investment Opportunity: The Monolithic Power Systems Lawsuit Investors in Monolithic Power Systems, Inc. (NASDAQ: MPWR) have a unique chance to engage in a securities fraud lawsuit that may lead to financial compensation. The lawsuit targets those who acquired common stock during a specified timeframe, raising awareness about the implications of their investments....
Continue Reading
Breaking New Ground in Fertility Treatment When it comes to fertility treatment, there are countless hopes tied up in embryonic success rates, especially when biology throws a fit. That's where Taiwan shines right now — introducing an AI-powered twist to the old embryo selection method. With the boom in infertility rates hitting one in six folks globally, here comes a...
Continue Reading
Hasbro's Innovative Shift Towards the Adult Toy Market Toy manufacturer Hasbro Inc. (NASDAQ: HAS) is making a noteworthy pivot to target a burgeoning market, focusing on adults and teens, often labeled as 'kidults.' This growing consumer segment is contributing significantly to toy-related expenditures, leading many to invest substantial amounts in collectibles and...
Continue Reading
Overview of BMO's Recent Dividend Announcement Bank of Montreal (TSX:BMO) recently revealed its decision to enhance the quarterly dividend on its common shares. This increase of 4 cents represents a growth of 3 percent from the previous quarter and a notable 5 percent from the same period last year. This strategic move is pleasing for shareholders, reflecting the...
Continue Reading